CAS No. 838834-84-7

4-Morpholineacetamide,N-[7-(dimethylamino)-5,8-dihydro-5,8-dioxo-6-quinoxalinyl]-N-methyl-

4-Morpholineacetamide,N-[7-(dimethylamino)-5,8-dihydro-5,8-dioxo-6-quinoxalinyl]-N-methyl-

Catalog No.1965976
Name4-Morpholineacetamide,N-[7-(dimethylamino)-5,8-dihydro-5,8-dioxo-6-quinoxalinyl]-N-methyl-
CAS 838834-84-7
FormulaC17H21N5O4

Dimethylamino

Request a Quote SDS

Structure of 838834-84-7

About 4-Morpholineacetamide,N-[7-(dimethylamino)-5,8-dihydro-5,8-dioxo-6-quinoxalinyl]-N-methyl-

4-Morpholineacetamide,N-[7-(dimethylamino)-5,8-dihydro-5,8-dioxo-6-quinoxalinyl]-N-methyl- is a chemical compound registered under CAS number 838834-84-7, with the molecular formula C17H21N5O4 and a molecular weight of about 359.39 g/mol. SACTG supplies 4-Morpholineacetamide,N-[7-(dimethylamino)-5,8-dihydro-5,8-dioxo-6-quinoxalinyl]-N-methyl- for laboratory research and bulk production; product code 1965976. Send an inquiry for purity, packaging, price and lead time.

CAS Number
838834-84-7
Molecular Formula
C17H21N5O4
Molecular Weight
359.39 g/mol
Related Keywords
dioxo
quinoxalinyl
dimethylamino
morpholineacetamide
  • [1-(4-METHYLBENZYL)-1H-BENZIMIDAZOL-2-YL]METHANOL
  • D-PROLINE,5-(1-METHYLETHYL)-,(5R)-REL-
  • 2H-Inden-2-one, 1,3-dihydro-1,4-dimethyl-1-(1-piperidinyl)-, oxime
  • L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-3-nitrotyrosyl-
  • 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[[4-(trifluoromethyl)phenyl]methyl]-
  • Benzene, 1-(3-butenyl)-2-[(S)-(4-methylphenyl)sulfinyl]-
    835626-67-0
  • bicyclo[2.2.1]hept-5-en-2-ylmethyl phenylcarbamate
  • Acetamide, N-acetyl-N-(4-methoxy-3,5-dinitrophenyl)-
  • Acetamide,N,N'-(1,4-diacetyl-1,2,3,4-tetrahydro-5,7-quinoxalinediyl)bis-
  • Acetamide,N-[1-[2-(acetyloxy)ethyl]-2,5-dimethyl-1H-benzimidazol-6-yl]-
  • 5(4H)-Thiazolone, 2-amino-4-[1,4-bis(benzoyloxy)-2-butenylidene]-,monohydrobromide
  • 1-deoxygluco-heptulose 2-phosphate
    92642-58-5
  • 1,1'-Biphenyl, 4-(2-propynyloxy)-
  • Tricyclo[4.3.1.01,8]decane
  • Urea,N'-[4-[2-(5-ethyl-2-pyridinyl)ethoxy]-3-(trifluoromethyl)phenyl]-N-methoxy-N-methyl-
  • 1H-Indene, 1-chloro-1-ethyl-2,3-dihydro-2-nitroso-
  • 3-Furancarboxylic acid, 5-ethenyl-2-[(1E)-2-ethoxyethenyl]tetrahydro-,methyl ester, (2R,3R,5R)-rel-
  • 3-Pyridineacetaldehyde, a-oxo-, aldoxime, (E)-
    92639-84-4
  • 2(1H)-Pyrazinone,3,6-dihydro-3-[(1R)-1-[(1R,2R)-2-hydroxycyclopropyl]-2-(phenylsulfonyl)ethyl]-5-methoxy-6-(1-methylethyl)-, (3S,6R)-
  • 1H-Imidazole, cobalt(2+) salt
  • 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[(2,6-dichlorophenyl)methyl]-
  • 1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID 2,5-DIHYDRO-2-METHYL-,METHYL ESTER
  • Ethenol,2-[(2R,3R,5R)-5-ethenyltetrahydro-3-[(4-methylphenyl)sulfonyl]-2-furanyl]-, acetate, rel-
  • 2-{[3-(1,3-benzodioxol-5-yl)-4-oxo-3,4-dihydroquinazolin-2-yl]sulfanyl}-N-ethyl-N-(3-methylphenyl)acetamide
    6195-80-8
  • Methyl, (2-oxo-1-pyrrolidinyl)-
  • L-Lysine,L-cysteinylglycyl-L-threonyl-L-a-aspartylglycyl-L-alanyl-L-a-glutamyl-L-lysylglycyl-L-prolyl-L-threonyl-L-tyrosyl-L-asparaginyl-L-lysyl-L-valyl-L-arginylglycyl-L-a-aspartyl-
  • CH3N3S
  • 1,2,4-Triazine-3,5(2H,4H)-dione, 2-[(2-fluoro-5-nitrophenyl)methyl]-
  • 1,2,4-Triazine-3,5(2H,4H)-dione, 4-(3-methyl-2-butenyl)-
  • Butanoic acid, 4,4,4-trifluoro-3-methyl-, (3R)-
    835629-56-6
  • [1,1'-Binaphthalen]-2-ol, 2'-[[(1R,2R)-2-(diethylamino)cyclohexyl]oxy]-,(1R)-
  • 1,2,4-Thiadiazole-3,5-dicarboxamide
  • 1-Triazene,3,3-diethyl-1-[2-[[2-ethynyl-5-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]ethynyl]-5-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-
  • 4,6-Bis-(trichloromethyl)-2-[(4-dimethylamino)-styryl]-1,3,5-triazine
  • 3-Butyn-2-ol,4-[2-[[2-iodo-4-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]ethynyl]-4-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-2-methyl-
  • Silane, (2-bromophenoxy)(1,1-dimethylethyl)diphenyl-
    835629-58-8